Application 020305
- Type
- NDA
- Sponsor
- ROCHE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | KYTRIL | GRANISETRON HYDROCHLORIDE | TABLET;ORAL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | Yes | No |
| 002 | KYTRIL | GRANISETRON HYDROCHLORIDE | TABLET;ORAL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020305-001 | KYTRIL | GRANISETRON HYDROCHLORIDE | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | |
| N020305-002 | KYTRIL | GRANISETRON HYDROCHLORIDE | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-03-16 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or efficacy reasons** | TABLET / ORAL | RLD | 1998-06-15 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020305-001 | KYTRIL | EQ 1MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-03-16 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020305-002 | KYTRIL | EQ 2MG BASE **Federal Register determination that product was not withdrawn or discontinued for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1998-06-15 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Eugia US LLC | 783e9d68-2371-4fd4-8d7a-a5e36f8718d0 | 2025-04-24 | Warnings, Adverse reactions | GRANISETRON HYDROCHLORIDE |
| Granisol | GRANISETRON HYDROCHLORIDE | Intra-Sana Laboratories | 2758eb4d-2fe0-4f74-b3f5-b4903009e97c | 2025-03-21 | Warnings, Adverse reactions | GRANISETRON HYDROCHLORIDE |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Breckenridge Pharmaceutical, Inc. | df4b6775-4337-41e0-815a-b064d98c3fe1 | 2024-02-29 | Warnings, Adverse reactions | GRANISETRON HYDROCHLORIDE |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | e07862df-f324-4575-a1ef-f7e1cbab4c7a | 2024-01-04 | Warnings, Adverse reactions | GRANISETRON HYDROCHLORIDE |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Bionpharma Inc. | 50b713d3-7ca8-465a-aefa-65ddbe17b934 | 2023-12-16 | Warnings, Adverse reactions | GRANISETRON HYDROCHLORIDE |
| Granisetron | GRANISETRON HYDROCHLORIDE | Fresenius Kabi USA, LLC | dddc8714-383f-4bc5-a468-ae89dbc802b4 | 2022-11-15 | Warnings, Adverse reactions | GRANISETRON HYDROCHLORIDE |
| Granisetron hydrochloride | GRANISETRON HYDROCHLORIDE | Natco Pharma Limited | d2be8de3-04fe-4e92-82b4-98d749b89596 | 2019-10-25 | Warnings, Adverse reactions | GRANISETRON HYDROCHLORIDE |
| Granisetron Hydrochloride | GRANISETRON HYDROCHLORIDE | Mylan Institutional LLC | 8d88adba-7f5e-4e97-84b3-6ca8ec98c023 | 2017-08-31 | Warnings, Adverse reactions | GRANISETRON HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.